Immunome (IMNM) surges after positive phase 3 results for varegacestat in desmoid tumors. Read the latest analysis on the ...
Structure Therapeutics, Inc. Sponsored ADR ( ($GPCR) ) has shared an announcement. On December 8, 2025, Structure ...
Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...
Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects ...
This research underscores the beneficial impact of the Medicaid Institution for Mental Diseases (IMD) exclusion waivers on psychiatric-specific and all-cause health care resource utilization and costs ...
First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...
Introduction Prescribing high-dose antipsychotics is typically reserved for individuals with treatment-resistant severe ...
The Indian Rupee loses ground as the US Dollar (USD) advances despite rising Fed rate cut bets. India’s economy likely expanded 7.3% in the July–September quarter, driven by robust rural demand and ...
The phase 3 MajesTEC-3 trial demonstrated that the combination of the bispecific BCMA-directed T-cell engager teclistamab and ...
The Indian Rupee slumps to its lowest level near 90.00 against the US Dollar amid continuous foreign outflow from the Indian equity market. India’s GDP growth surprisingly remained stronger at 8.2% in ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results